Mum-of-two given devastating 'one year to live' cancer diagnosis now clear due to miraculous treatment

A mum-of-two with severe breast cancer was given just one year to live. But after taking part in a clinical trial with experimental medicines, she has now been miraculously cleared.

When Jasmin David discovered that her cancer had spread to the lungs, lymph nodes and chest bone, she was given the devastating news that she had less than a year to live. The previously fit and healthy mother of two grown-up children, who worked in a care home for the elderly, discovered she had an aggressive triple negative form of breast cancer in November 2017.

Jasmin, 51, became suspicious when she found a lump above the nipple. She then underwent a gruelling six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy which cleared her body of cancer.

But in October 2019, the family's worst nightmare became real. The cancer returned and scans showed multiple lesions throughout her body meaning she had a poor prognosis.

READ MORE : Warning that UK could be on the brink of new Covid wave with virus becoming 'more dangerous'

Two months later, and with no other options left, Jasmin was offered the opportunity to be part of research by participating in a phase I (early phase) clinical trial. In December 2019 Jasmin began a two-year trial at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie in Manchester.

Jasmin, from Fallowfield, was given an experimental medicine combined with Atezolizumab, an immunotherapy drug administered intravenously which she continues to have every three weeks. Now, the beloved mother is showing no evidence of the disease - enjoying life with her husband David and their grown-up children, Ryan and Riona.

“